Valuein

Overview

LyondellBasell Industries N.V.

LYBNYSEMaterialsIndustrial Organic ChemicalsCIK 0001489393Large-cap benchmark

Latest 10-K: FY2025, filed Feb 20, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$30.15B
9.7%YoYdown from FY2024
TotalRevenue
Gross profit
$2.58B
44.5%YoYdown from FY2024
GrossProfit
Operating income
-$0.42B
121.9%YoYdown from FY2024
OperatingIncome
Diluted EPS
-$2.34
156.4%YoYdown from FY2024
EPSDiluted
Free cash flow
$0.38B
80.6%YoYdown from FY2024

At a glance

Growth

  • LyondellBasell Industries N.V. reported revenue of $30.15B for fiscal 2025, down 9.7% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 1 of the last 5 fiscal years.

Profitability

  • Operating margin was -1.4%.

Per share

  • Diluted EPS was -$2.34, down 156.4% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$30.15B9.7%down
Benchmark median 6.4%
$33.39B0.2%up
Benchmark median 4.5%
$33.34B33.9%down
Benchmark median 4.8%
$50.45B9.3%up
Benchmark median 10.3%
$46.17B66.4%up
Benchmark median 13.8%
-10.1%
Benchmark median 6.6%
Gross Profit
Median of 315 / 498
$2.58B44.5%down
Benchmark median 6.8%
$4.64B5.2%down
Benchmark median 5.5%
$4.90B25.8%down
Benchmark median 5.2%
$6.60B24.7%down
Benchmark median 8.3%
$8.78B158.6%up
Benchmark median 15.7%
-26.4%
Benchmark median 6.2%
Operating Income
Median of 373 / 498
negative: -$0.42B121.9%down
Benchmark median 7.3%
$1.92B29.6%down
Benchmark median 7.4%
$2.73B46.6%down
Benchmark median 4.9%
$5.10B24.7%down
Benchmark median 7.5%
$6.77B334.4%up
Benchmark median 23.5%
n/m
Benchmark median 7.2%
Net Income
—
—
—
—
—
—
Benchmark median 4.1%
EPS (Diluted)
negative: -$2.34156.4%down
Benchmark median 6.2%
$4.1535.8%down
Benchmark median 7.9%
$6.4645.3%down
Benchmark median 1.9%
$11.8129.5%down
Benchmark median 1.5%
$16.75295.0%up
Benchmark median 34.8%
n/m
Benchmark median 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$34.00B4.9%down
Benchmark median 5.6%
$35.75B3.4%down
Benchmark median 3.4%
$37.00B1.7%up
Benchmark median 4.1%
$36.37B1.0%down
Benchmark median 2.2%
$36.74B3.8%up
Benchmark median 6.7%
-1.9%
Benchmark median 4.7%
Total Liabilities
Median of 357 / 498
—
—
—
—
—
—
Benchmark median 4.4%
Stockholders' Equity
$10.09B19.1%down
Benchmark median 6.8%
$12.47B3.6%down
Benchmark median 5.4%
$12.94B2.5%up
Benchmark median 7.3%
$12.63B6.4%up
Benchmark median 2.5%
$11.87B48.6%up
Benchmark median 9.0%
-4.0%
Benchmark median 6.1%
Cash & Equivalents
$3.44B2.0%up
Benchmark median 5.2%
$3.38B0.4%down
Benchmark median 1.9%
$3.39B57.6%up
Benchmark median 6.7%
$2.15B46.1%up
Benchmark median -8.6%
$1.47B16.5%down
Benchmark median -2.9%
23.7%
Benchmark median 2.0%
Total Debt
$12.71B15.2%up
Benchmark median 2.1%
$11.03B0.8%down
Benchmark median 0.2%
$11.12B1.3%up
Benchmark median 0.3%
$10.97B2.5%down
Benchmark median 0.1%
$11.25B26.4%down
Benchmark median -0.1%
3.1%
Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$2.26B40.8%down
Benchmark median 6.3%
$3.82B22.7%down
Benchmark median 4.8%
$4.94B19.2%down
Benchmark median 9.9%
$6.12B20.5%down
Benchmark median -0.7%
$7.70B126.1%up
Benchmark median 10.7%
-26.4%
Benchmark median 7.0%
Capital Expenditures
$1.88B2.1%up
Benchmark median 5.4%
$1.84B20.1%up
Benchmark median 2.8%
$1.53B19.0%down
Benchmark median 11.3%
$1.89B3.5%down
Benchmark median 14.0%
$1.96B0.6%up
Benchmark median 8.1%
-1.1%
Benchmark median 9.0%
Free Cash Flow
Median of 378 / 498
$0.38B80.6%down
Benchmark median 7.3%
$1.98B42.0%down
Benchmark median 6.1%
$3.41B19.3%down
Benchmark median 8.8%
$4.23B26.3%down
Benchmark median -11.3%
$5.74B293.7%up
Benchmark median 10.2%
-49.1%
Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

n/m

Wall Street

on net earnings

FY2024 5.6%

— Not reported

Value investor

on free cash flow

FY2024 — Not reported

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E n/m

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on LYB yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on LYB and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/LYB

APA-style text
Valuein. (2026, October 31). LyondellBasell Industries N.V. (LYB) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/LYB
BibTeX
@misc{valuein_lyb_2026,
  author = {{Valuein}},
  title = {LyondellBasell Industries N.V. (LYB) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/LYB}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Feb 20, 2026 · accession 0001489393-26-000012

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.